(19)

(11)

EP 4 561 622 A1

(12)

(43) Date of publication: 04.06.2025 Bulletin 2025/23 (21) Application number: 23748067.8 (22) Date of filing: 26.07.2023

(51) International Patent Classification (IPC):  A61K 39/395(2006.01) C07K 5/02(2006.01) C07K 16/40(2006.01) A61P 35/00(2006.01) C07K 14/315(2006.01) (52) Cooperative Patent Classification (CPC): C07K 16/40; A61P 35/00; A61K 39/395; G01N 33/57492; A61K 47/6871; G01N 2333/948; G01N 2800/52; A61K 47/6803; A61K 47/6889 (86) International application number: PCT/EP2023/070715 (87) International publication number: WO 2024/023159 (01.02.2024 Gazette 2024/05)

(84) Designated Contracting States: AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC ME MK MT NL NO PL PT RO RS SE SI SK SM TR Designated Extension States: BA Designated Validation States: KH MA MD TN (30) Priority: 26.07.2022 EP 22382713 (71) Applicant: Oncomatryx Biopharma, S.L. 48160 Derio (Vizcaya) (ES)	(72) Inventors: FABRE, Myriam DERIO (ES) FERRER, Cristina DERIO (ES) GARCIA, Ribas Ignacio DERIO (ES) MORENO, Ruiz Pablo Derio (ES) SIMON, Laureano Derio (ES) (74) Representative: Mewburn Ellis LLP  Aurora Building Counterslip Bristol BS1 6BX Bristol BS1 6BX (GB)